A detailed history of Liberty One Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Liberty One Investment Management, LLC holds 101,739 shares of GILD stock, worth $6.98 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
101,739
Previous 101,794 0.05%
Holding current value
$6.98 Million
Previous $8.25 Million 9.63%
% of portfolio
0.85%
Previous 1.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$71.58 - $87.29 $3,936 - $4,800
-55 Reduced 0.05%
101,739 $7.45 Million
Q4 2023

Jan 26, 2024

BUY
$73.27 - $83.09 $116,645 - $132,279
1,592 Added 1.59%
101,794 $8.25 Million
Q3 2023

Nov 03, 2023

SELL
$73.94 - $80.67 $3.02 Million - $3.3 Million
-40,863 Reduced 28.97%
100,202 $7.51 Million
Q2 2023

Aug 04, 2023

BUY
$76.01 - $86.7 $160,533 - $183,110
2,112 Added 1.52%
141,065 $10.9 Million
Q1 2023

May 15, 2023

SELL
$77.31 - $88.08 $2.6 Million - $2.97 Million
-33,672 Reduced 19.51%
138,953 $11.5 Million
Q4 2022

Feb 15, 2023

SELL
$62.32 - $89.47 $695,615 - $998,664
-11,162 Reduced 6.07%
172,625 $14.8 Million
Q3 2022

Nov 16, 2022

BUY
$59.54 - $68.01 $881,787 - $1.01 Million
14,810 Added 8.76%
183,787 $11.3 Million
Q2 2022

Aug 01, 2022

SELL
$57.72 - $65.01 $417,257 - $469,957
-7,229 Reduced 4.1%
168,977 $11.6 Million
Q1 2022

May 03, 2022

BUY
$57.92 - $72.58 $238,977 - $299,465
4,126 Added 2.4%
176,206 $10.5 Million
Q4 2021

Jan 21, 2022

BUY
$64.88 - $73.64 $275,934 - $313,190
4,253 Added 2.53%
172,080 $12.5 Million
Q3 2021

Oct 20, 2021

SELL
$67.69 - $73.03 $77,843 - $83,984
-1,150 Reduced 0.68%
167,827 $11.7 Million
Q2 2021

Jul 20, 2021

BUY
$63.47 - $69.35 $400,241 - $437,321
6,306 Added 3.88%
168,977 $11.6 Million
Q1 2021

Apr 06, 2021

BUY
$60.0 - $68.46 $9.76 Million - $11.1 Million
162,671 New
162,671 $10.5 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $86B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Liberty One Investment Management, LLC Portfolio

Follow Liberty One Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty One Investment Management, LLC with notifications on news.